TN2013000068A1 - Anti-vegfr-3 antibody compositions - Google Patents

Anti-vegfr-3 antibody compositions

Info

Publication number
TN2013000068A1
TN2013000068A1 TNP2013000068A TN2013000068A TN2013000068A1 TN 2013000068 A1 TN2013000068 A1 TN 2013000068A1 TN P2013000068 A TNP2013000068 A TN P2013000068A TN 2013000068 A TN2013000068 A TN 2013000068A TN 2013000068 A1 TN2013000068 A1 TN 2013000068A1
Authority
TN
Tunisia
Prior art keywords
vegfr
antibody compositions
antibodies
disease
treatment
Prior art date
Application number
TNP2013000068A
Other languages
French (fr)
Inventor
Bronislaw Pytowski
Krishnadatt Persaud
Nathalie Zayek
Original Assignee
Imclone Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/050131 external-priority patent/WO2012033696A1/en
Application filed by Imclone Llc filed Critical Imclone Llc
Publication of TN2013000068A1 publication Critical patent/TN2013000068A1/en

Links

Abstract

The present invention provides anti-VEGFR-3 monoclonal antibodies, pharmaceutical compositions containing said antibodies and uses of said antibodies in the treatment of disease.
TNP2013000068A 2011-09-01 2013-02-18 Anti-vegfr-3 antibody compositions TN2013000068A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/050131 WO2012033696A1 (en) 2010-09-07 2011-09-01 Anti-vegfr-3 antibody compositions

Publications (1)

Publication Number Publication Date
TN2013000068A1 true TN2013000068A1 (en) 2014-06-25

Family

ID=54360767

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000068A TN2013000068A1 (en) 2011-09-01 2013-02-18 Anti-vegfr-3 antibody compositions

Country Status (1)

Country Link
TN (1) TN2013000068A1 (en)

Similar Documents

Publication Publication Date Title
MX356337B (en) Antibodies against human csf-1r and uses thereof.
MX336682B (en) Antibodies against human csf-1r and uses thereof.
TN2015000396A1 (en) Antibody drug conjugates
MX2019006362A (en) Composition comprising two antibodies engineered to have reduced and increased effector function.
SG194701A1 (en) Anti-cd40 antibodies and methods of use
NZ707086A (en) Anti-cd40 antibodies and methods of use
MX2016008098A (en) Bispecific her2 antibodies and methods of use.
MX2013009362A (en) Antibody against the csf-1r.
MA34091B1 (en) Antibody antibody cd40
MX2015012122A (en) Antibody drug conjugates and corresponding antibodies.
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
SG178886A1 (en) Humanized anti-cdcp1 antibodies
PH12017500864A1 (en) Anti-notch1 antibodies
PH12014502406B1 (en) Anti-il-23p19 antibodies
MX2014012978A (en) Modified antibody regions and uses thereof.
MX2013009151A (en) Improved immunotherapy.
MX346500B (en) Methods and compositions for neural disease immunotherapy.
TN2013000378A1 (en) Anti - sclerostin antibody crystals and formulations thereof
WO2014163714A3 (en) Antibody drug conjugates
TN2015000277A1 (en) Bmp-6 antibodies
MX2015008534A (en) ANTI- INTEGRIN ß1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF.
MX2013002718A (en) Anti-vegfr-3 antibody compositions.
MX2013011629A (en) Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists.
PH12015501650A1 (en) Human antibody specific to human metapneumovirus, or antigen-binding fragment thereof
TN2013000068A1 (en) Anti-vegfr-3 antibody compositions